A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
This research study, called ATTAIN-Hypertension, is investigating a new medication, orforglipron, for adults who have high blood pressure and are also overweight or living with obesity. The main goal is to find out if orforglipron is effective in lowering blood pressure and to check how safe it is for people to use. Participants will be randomly assigned to either receive the new medicine or a 'dummy' pill (placebo) that looks the same but contains no active drug. This is a common way to test new treatments, helping researchers understand the medicine's true effects. It's part of a larger research programme looking into orforglipron.
Auf einen Blick
Worum geht es in dieser Studie?
This study, known as ATTAIN-Hypertension, is a clinical trial focused on a new medicine called orforglipron (which has a code name LY3502970). The main purpose of this research is to see if orforglipron can help people who have high blood pressure, especially if they are also overweight or living with obesity. High blood pressure can lead to serious health problems like heart attacks and strokes, so finding effective treatments is very important.
Researchers want to understand two key things: first, if orforglipron actually works to lower blood pressure in this group of people (this is called its 'efficacy'), and second, whether it is safe to use and what side effects it might have (this is called its 'safety'). To do this, some people in the study will receive orforglipron, while others will receive a 'placebo', which looks identical but doesn't contain any active medicine. This allows doctors to compare the results and see if the new medicine is having a real effect.
This specific study is part of a bigger research effort investigating orforglipron. By participating, you would be helping medical science learn more about how to treat high blood pressure in people who also struggle with their weight, potentially leading to new treatment options in the future.
Wichtige Erkenntnisse
- The study is testing a new medicine, orforglipron, for high blood pressure.
- It's for adults who also have obesity or are overweight.
- The goal is to check how well the medicine works and if it's safe.
- Some participants will get the actual medicine, others a dummy pill.
- Participation involves regular clinic visits and health checks.
- Sie können die Studie jederzeit verlassen, wenn Sie Ihre Meinung ändern.
Wer könnte berechtigt sein?
To be considered for this study, you must be 18 years old or older. The study is open to both men and women.
Since this study is part of a larger research programme, there are specific guidelines that decide who can and cannot take part. These guidelines are carefully considered to make sure the study is safe for everyone involved and that the results are clear.
If you are interested, a member of the research team will explain these guidelines in detail and check if you meet all the necessary requirements for screening. They will ask questions about your health and medical history.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie 18 Jahre alt oder älter?
- Do you have high blood pressure?
- Are you currently overweight or living with obesity?
- Können Sie regelmäßige Kliniktermine wahrnehmen?
Was beinhaltet die Teilnahme?
Taking part in this study would involve a series of visits to the clinic over a period of time. During these visits, you would have various health checks, such as measurements of your blood pressure, weight, and blood tests. You would be given either the study medicine (orforglipron) or a dummy pill (placebo) to take regularly, as instructed by the study team.
The specific number of visits and the total length of your participation would be explained fully by the study team during your initial conversations. There will also be follow-up appointments to monitor your health and how you are responding to the medication. All procedures, including medication doses and the duration of the study, will be carefully set out in the study plan.
Potenzielle Risiken und Vorteile
Locations (99)
- Elite Clinical Studies, LLCVerifizierte PostleitzahlPhoenix, Vereinigte Staaten
- Valley Clinical Trials, Inc.Verifizierte PostleitzahlCovina, Vereinigte Staaten
- Valley Clinical Trials, Inc.Verifizierte PostleitzahlNorthridge, Vereinigte Staaten
- Chase Medical Research, LLCVerifizierte PostleitzahlWaterbury, United States
- Excel Medical Clinical TrialsVerifizierte PostleitzahlBoca Raton, Vereinigte Staaten
- Care Access - BrandonVerifizierte PostleitzahlBrandon, United States
- Northeast Research Institute - Downtown OfficeVerifizierte PostleitzahlJacksonville, Vereinigte Staaten
- Peace River Cardiovascular CenterVerifizierte PostleitzahlPort Charlotte, United States
- East-West Medical Research InstituteVerifizierte PostleitzahlHonolulu, Vereinigte Staaten
- Sinai Hospital Of BaltimoreVerifizierte PostleitzahlBaltimore, Vereinigte Staaten
- Ascension Saint Agnes Heart CareVerifizierte PostleitzahlBaltimore, Vereinigte Staaten
- Lucida Clinical TrialsVerifizierte PostleitzahlNew Bedford, United States
Häufige Fragen
Was ist Bluthochdruck?
High blood pressure, or hypertension, means your blood is pushing too hard against the walls of your arteries. Over time, this can damage your blood vessels and lead to serious health problems like heart disease or stroke.
What is 'obesity or overweight' in this study?
This refers to having a body weight that is higher than what is considered healthy for your height. The study will use specific measurements, like Body Mass Index (BMI), to determine this.
Was ist ein 'Placebo'?
A placebo is a 'dummy' pill or treatment that looks exactly like the real medicine but contains no active drug. It helps researchers see if the real medicine is actually working or if improvements are due to other factors.
Werde ich wissen, ob ich das echte Medikament oder das Placebo erhalte?
No, neither you nor the study team will know whether you are receiving the active medicine or the placebo. This is to ensure the study results are fair and unbiased. This is called 'blinding'.
Kann ich die Teilnahme an der Studie beenden, wenn ich möchte?
Yes, absolutely. Your participation is completely voluntary, and you can choose to leave the study at any time, for any reason, without it affecting your future medical care.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.